Article
Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.
Current eye research - 1 May 2010
Landreville Solange, Ma Duanduan, Wu Jun, Harbour J William
Abstract excerpt
PURPOSE: In some cancers, the oncogenic consequences of inactivating the retinoblastoma protein (Rb) appear to be mediated by unrestrained activity of the inhibitor of DNA binding protein Id2. The role of Id2 has not yet been investigated in the prototype cancer Rb-defective cancer, retinoblastoma itself. This study investigated whether loss of Id2 modified the effects of Rb inactivation in a mouse model of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
